Hangzhou Huisheng Biotech Pharmaceutical Co., Ltd.
|
Sulfobutyl ether - β-cyclodextrin sodium is a new drug preparation excipient, which is a sulfonyl derivative of anionic highly water-soluble cyclodextrin. It can be well integrated with drug molecules to form non-co-chemicalbook valence complex, improve drug stability, water solubility, safety, and effectively improve the biological activity of drug molecules. It has little renal toxicity, can alleviate hemolytic drug, control drug release rate. |
Send Inquiry
|
RON PHARM(SHANGHAI)CO.,LIMITED
|
CycloLab started as a spin-off of Sanofi-Aventis Chinoin Pharma (1990) Over 40-year experience in all fields of CD-technology.
CycloLab produce sulfobutylether beta-cyclodextrin (SBECD, Dexolve™) in multiple ton scale annually under cGMP conditions based on an FDA-approved Drug Master File and CTD Format Dossier
DexolveTM is used in commercialand development phases for over 20 APIs by dozens of clients.
CycloLab's business model is free from license, milestone- and royalty payments |
Send Inquiry
|